We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Ranked Momentum Stocks to Buy for September 27th
Read MoreHide Full Article
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 27th:
Aclaris Therapeutics, Inc. (ACRS - Free Report) : This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.
American Electric Power (AEP - Free Report) : This electric public utility holding company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.
American Electric Power Company, Inc. Price and Consensus
Ally Financial Inc. (ALLY - Free Report) : This provider of financial products and services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for September 27th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 27th:
Aclaris Therapeutics, Inc. (ACRS - Free Report) : This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.
Aclaris Therapeutics, Inc. Price and Consensus
Aclaris Therapeutics, Inc. price-consensus-chart | Aclaris Therapeutics, Inc. Quote
Aclaris Therapeutics' shares gained 23% over the last one month compared to S&P 500’s rise of 4%. The company possesses a Momentum Score of A.
Aclaris Therapeutics, Inc. Price
Aclaris Therapeutics, Inc. price | Aclaris Therapeutics, Inc. Quote
American Electric Power (AEP - Free Report) : This electric public utility holding company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.
American Electric Power Company, Inc. Price and Consensus
American Electric Power Company, Inc. price-consensus-chart | American Electric Power Company, Inc. Quote
American Electric Power's shares gained 4.3% over the last one month. The company possesses a Momentum Score of A.
American Electric Power Company, Inc. Price
American Electric Power Company, Inc. price | American Electric Power Company, Inc. Quote
Ally Financial Inc. (ALLY - Free Report) : This provider of financial products and services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.
Ally Financial Inc. Price and Consensus
Ally Financial Inc. price-consensus-chart | Ally Financial Inc. Quote
Air Industries’ shares gained 10.2% over the last one month. The company possesses a Momentum Score of B.
Ally Financial Inc. Price
Ally Financial Inc. price | Ally Financial Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>